TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2612495

Group type: EXPERIMENTAL
Intervention: Lamotrigine (Lamictal) as add-on therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 34
Study: 944387

Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: levodopa with L-tryptophan
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: withdrawal from levodopa
Number of subjects: 100
Study: 29093159

Group type: EXPERIMENTAL
Intervention: CNTO6785 15, 50, 100, or 200 mg every 4 weeks + MTX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + MTX
Number of subjects: 0
Study: 27552276

Group type: EXPERIMENTAL
Intervention: Stand-biased desks for 2 consecutive years
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard desks during both years
Number of subjects: 380
Study: 24534270

Group type: EXPERIMENTAL
Intervention: Accumulated brisk walking (3 × 10 minutes, 5 days/week) with telephone support
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group performing stretching exercises
Number of subjects: 77
Study: 22505632

Group type: EXPERIMENTAL
Intervention: Minocycline (7 days of intravenous administration)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 20518927

Group type: COMPARATOR
Intervention: Control (G1 - sound teeth)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MOD cavity preparation (G2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MOD + root canal treatment (G3)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MOD + Endo + composite resin restoration (G4)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MOD + Endo + unidirectional fibre + Resin (G5)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MOD + Endo + woven fibre + Resin (G6)
Number of subjects: 90
Study: 18291724

Group type: EXPERIMENTAL
Intervention: Intravenous levetiracetam (LEV)
Number of subjects: 50
Study: 15969830

Group type: EXPERIMENTAL
Intervention: Adult guidance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer discussion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adult-child condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 0
Study: 14569170

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 49

Group type: COMPARATOR
Intervention: Medical therapy (Control)
Number of subjects: 49

Group type: COMPARATOR
Intervention: 201Tl rest
Number of subjects: 49

Group type: COMPARATOR
Intervention: 201Tl redistribution
Number of subjects: 49

Group type: COMPARATOR
Intervention: 18F-FDG
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Echocardiography (Revascularized patients)
Number of subjects: 49
Study: 10919601

Group type: EXPERIMENTAL
Intervention: 3.0 mM supplemental GSH to perfusate
Number of subjects: 100

Group type: COMPARATOR
Intervention: No supplementation (control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Machine perfusion (MP) in UW-machine perfusate solution (MPS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cold storage (CS) in UW
Number of subjects: 100
Study: 9344049

Group type: EXPERIMENTAL
Intervention: Hyperactive group (HA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Hyperactive/conduct-disordered group (HA+CD)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Conduct-disordered group (CD)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Normal control group (N)
Number of subjects: 4
Study: 8229721

Group type: EXPERIMENTAL
Intervention: True Vista bifocal IOL
Number of subjects: 446
Study: 3542325

Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate (250 mg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Metoclopramide hydrochloride (10 mg)
Number of subjects: 115
Study: 30968534

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 6609

Group type: COMPARATOR
Intervention: Non-Chinese herbal medicine users (controls)
Number of subjects: 6609

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs) for over 2 years
Number of subjects: 6609
Study: 28444574

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (six home visits)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 130
Study: 27373452

Group type: EXPERIMENTAL
Intervention: Unilateral transvenous phrenic nerve stimulation (remede(R) System)
Number of subjects: 47
Study: 24835503

Group type: EXPERIMENTAL
Intervention: TGF-β1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PLN inhibition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 23134887

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplementation (vitamin B complex and vitamins C and E)
Number of subjects: 2387

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplementation (vitamin B complex and vitamins C and E) among children whose mothers received ARV therapy
Number of subjects: 2387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2387
Study: 20504786

Group type: EXPERIMENTAL
Intervention: MIRROR
Number of subjects: 34

Group type: COMPARATOR
Intervention: DIRECT
Number of subjects: 34
Study: 18822796

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestions of analgesia during different conditions (pre-hypnosis, neutral hypnosis, suggestions for analgesia, posthypnotic conditions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suggestions for analgesia administered after a mental stress instead of neutral hypnosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypnotic relaxation and suggestions of analgesia in healthy Lows receiving nociceptive stimulation
Number of subjects: 0
Study: 16040874

Group type: EXPERIMENTAL
Intervention: Asthma clubs intervention (weekly sessions over 8 weeks)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Delayed group (control)
Number of subjects: 173
Study: 11778093

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine (group R, n=22)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine (group L, n=22)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (group B, n=22)
Number of subjects: 66
Study: 9569656

Group type: EXPERIMENTAL
Intervention: Attention focused on self with personal failure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention focused on experimenter with personal failure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention focused on self or experimenter with universal failure
Number of subjects: 0
Study: 7819687

Group type: EXPERIMENTAL
Intervention: Vaginal douche with chlorhexidine solution (method I)
Number of subjects: 2853

Group type: COMPARATOR
Intervention: Chlorhexidine gluconate obstetrical gel during vaginal exploration (method II)
Number of subjects: 2853
Study: 3047334

Group type: EXPERIMENTAL
Intervention: Haloperidol plus dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prochlorperazine plus dexamethasone
Number of subjects: 0
Study: 1357913

Group type: EXPERIMENTAL
Intervention: Topical 1% apraclonidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 40
Study: 635479

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 16

Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 16
Study: 31608926

Group type: EXPERIMENTAL
Intervention: Cotadutide (50-300 µg, once-daily subcutaneous)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 30672346

Group type: EXPERIMENTAL
Intervention: Revised Malay HA manual
Number of subjects: 90

Group type: COMPARATOR
Intervention: Translated Malay HA manual
Number of subjects: 90
Study: 28510573

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Chloroquine + Primaquine (CQ+PQ)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine + Primaquine (AL+PQ)
Number of subjects: 398
Study: 26863738

Group type: EXPERIMENTAL
Intervention: Cycloferon
Number of subjects: 6034

Group type: EXPERIMENTAL
Intervention: Omega-3
Number of subjects: 6034

Group type: COMPARATOR
Intervention: Etiotropic therapy with treatment and rehabilitation measures
Number of subjects: 6034

Group type: COMPARATOR
Intervention: Etiotropic therapy alone
Number of subjects: 6034
Study: 23625101

Group type: EXPERIMENTAL
Intervention: COPE program (educational-behavioral parent intervention in the NICU)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control group (mothers over 21 years old)
Number of subjects: 253
Study: 20573162

Group type: EXPERIMENTAL
Intervention: YSPSL (rPSGL-Ig)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 19852829

Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Weekly chloroquine
Number of subjects: 242
Study: 16899213

Group type: EXPERIMENTAL
Intervention: Self-help based on cognitive behaviour therapy with Internet support
Number of subjects: 73

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 73
Study: 15364311

Group type: EXPERIMENTAL
Intervention: Nitrofurazone-coated catheters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard silicone urinary catheters
Number of subjects: 0
Study: 11512247

Group type: COMPARATOR
Intervention: Phenylephrine 5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phenylephrine 10%
Number of subjects: 30
Study: 9766455

Group type: EXPERIMENTAL
Intervention: IBS-SX group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 7819357

Group type: EXPERIMENTAL
Intervention: Spermicidal contraception (Nonoxynol-9)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Non-spermicidal contraception
Number of subjects: 179
Study: 3046630

Group type: EXPERIMENTAL
Intervention: Urapidil (30 to 90 mg bid)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Captopril (12.5 to 50 mg bid)
Number of subjects: 295
Study: 31096815

Group type: EXPERIMENTAL
Intervention: Gestational diabetes (GDM)
Number of subjects: 614
Study: 30009672

Group type: EXPERIMENTAL
Intervention: Three-dimensional-printed wrist orthosis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cock-up orthosis
Number of subjects: 22
Study: 27790809

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg once daily for 24 weeks
Number of subjects: 241

Group type: COMPARATOR
Intervention: placebo for 24 weeks
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg once daily
Number of subjects: 241

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 241
Study: 26231755

Group type: EXPERIMENTAL
Intervention: Peer benchmarked patient-reported outcome measures (PROMs) feedback and education
Number of subjects: 550

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 550
Study: 23623012

Group type: EXPERIMENTAL
Intervention: Phytosterol capsules (2.0 g/d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sunflower oil (placebo)
Number of subjects: 41
Study: 21324289

Group type: EXPERIMENTAL
Intervention: Ion-exchange water softener plus usual eczema care (group A)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Usual eczema care alone (group B)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Ion-exchange water softener (group A)
Number of subjects: 336
Study: 18795253

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) at ≤1.4 microg kg(‐1) h(‐1); n = 41
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard care (SC, either propofol or midazolam); n = 44
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 85
Study: 17085157

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg (single doses)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg + Tamsulosin 0.4 mg (once daily for up to 14 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg + Tamsulosin 0.4 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg
Number of subjects: 16
Study: 15248191

Group type: EXPERIMENTAL
Intervention: Verapamil (doses of 120, 180, 360, or 540 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population spline model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sparse data (66% randomly removed from placebo and active phases)
Number of subjects: 0
Study: 11483144

Group type: EXPERIMENTAL
Intervention: Adderall (mixed amphetamine salts compound) at an average oral dose of 54 mg (administered in 2 daily doses)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 9710010

Group type: EXPERIMENTAL
Intervention: Patients with ALS
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group A (other neurologic or muscular diseases)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group B (without neurologic disorders)
Number of subjects: 8
Study: 7821320

Group type: EXPERIMENTAL
Intervention: Flecainide (2 mg.kg‐1 intravenous bolus in 10 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Dofetilide (8 micrograms.kg‐1 maximum intravenous bolus in 15 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 21
Study: 2837895

Group type: EXPERIMENTAL
Intervention: Medium viscosity solid or liquid guar gum
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High viscosity liquid guar gum
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31462812

Group type: COMPARATOR
Intervention: Fentanyl 2 μg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fentanyl 3 μg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fentanyl 4 μg/kg
Number of subjects: 120
Study: 29415837

Group type: EXPERIMENTAL
Intervention: MCT/SOY
Number of subjects: 49

Group type: COMPARATOR
Intervention: SMOF
Number of subjects: 49
Study: 25521460

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment applied twice weekly
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 23388554

Group type: EXPERIMENTAL
Intervention: Video-based messages
Number of subjects: 139

Group type: COMPARATOR
Intervention: Text-based messages
Number of subjects: 139
Study: 21505316

Group type: EXPERIMENTAL
Intervention: VivaGel
Number of subjects: 61

Group type: COMPARATOR
Intervention: VivaGel placebo
Number of subjects: 61

Group type: COMPARATOR
Intervention: HEC placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: VivaGel and VivaGel placebo
Number of subjects: 61
Study: 19339966

Group type: EXPERIMENTAL
Intervention: Pregnenolone (fixed escalating doses to 500 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pregnenolone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Pregnenolone and Placebo
Number of subjects: 21
Study: 16940442

Group type: EXPERIMENTAL
Intervention: Testosterone gel (100 mg daily) + Depomedroxyprogesterone acetate (DMPA, 300 mg/3 months)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Testosterone gel (100 mg daily) + Depomedroxyprogesterone acetate (DMPA, 300 mg/3 months) + Acyline (300 microg/kg every 2 weeks for 12 weeks)
Number of subjects: 44
Study: 15311723

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 10
Study: 10687811

Group type: EXPERIMENTAL
Intervention: Collaborative research model implementation
Number of subjects: 0
Study: 9198088

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES) at 15 mA, 200 microseconds, with varying frequencies (0.1, 0.2, 0.3, 0.5, and 1 Hz)
Number of subjects: 13
Study: 8238182

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 283
Study: 4036786

Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 23

Group type: COMPARATOR
Intervention: Renografin‐76 (sodium meglumine diatrizoate)
Number of subjects: 23
Study: 30346618

Group type: EXPERIMENTAL
Intervention: Clipping
Number of subjects: 327

Group type: COMPARATOR
Intervention: Coiling
Number of subjects: 327
Study: 29532059

Group type: EXPERIMENTAL
Intervention: LINK LA Peer Navigation intervention
Number of subjects: 356

Group type: COMPARATOR
Intervention: Transitional case management (control)
Number of subjects: 356
Study: 26150057

Group type: EXPERIMENTAL
Intervention: Paroxetine combined with cognitive‐behavioral therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Paroxetine combined with cognitive‐behavioral therapy and virtual reality exposure
Number of subjects: 99

Group type: COMPARATOR
Intervention: Paroxetine only
Number of subjects: 99
Study: 24925090

Group type: COMPARATOR
Intervention: 200 mg entacapone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 25 mg opicapone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 50 mg opicapone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 75 mg opicapone
Number of subjects: 80

Group type: COMPARATOR
Intervention: entacapone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: opicapone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: all active treatments
Number of subjects: 80
Study: 23862255

Group type: EXPERIMENTAL
Intervention: Plain bupivacaine 10 mg with 25 mcg of fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine 10 mg with 25 mcg of fentanyl
Number of subjects: 60
Study: 19166763

Group type: EXPERIMENTAL
Intervention: Apexum procedure
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 48
Study: 17181461

Group type: EXPERIMENTAL
Intervention: Social marketing campaign intervention over 12 weeks at experimental sites.
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no intervention) at control sites.
Number of subjects: 4
Study: 15893158

Group type: EXPERIMENTAL
Intervention: 10 US dollars cash incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 US dollars cash incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 70 US dollars cash incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 US dollars gift certificate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 US dollars gift certificate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 70 US dollars gift certificate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher payments (cash or gift certificate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher magnitude payments
Number of subjects: 0
Study: 12485511

Group type: EXPERIMENTAL
Intervention: Nausea disintegrating buccal tablet (DBT) 0.1 mg before chemotherapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Kytril tablet 2 mg after chemotherapy
Number of subjects: 73
Study: 9802273

Group type: EXPERIMENTAL
Intervention: Active treatment (nitrendipine 10-40 mg/day, possibly with enalapril 5-20 mg/day, hydrochlorothiazide 12.5-25 mg/day)
Number of subjects: 2418

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 2418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2418
Study: 7895926

Group type: EXPERIMENTAL
Intervention: Amoxicillin (1 g twice daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Clarithromycin (500 mg twice daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg twice daily for 14 days, then 20 mg once in the morning for 28 days)
Number of subjects: 50
Study: 2013669

Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg by mouth
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6335005

Group type: EXPERIMENTAL
Intervention: Functioning TENS units
Number of subjects: 31

Group type: COMPARATOR
Intervention: Non-functioning TENS units
Number of subjects: 31
Study: 30500110

Group type: EXPERIMENTAL
Intervention: Maalox Max (magnesium and aluminum hydroxides plus simethicone)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 5-hydroxy saxagliptin
Number of subjects: 15
Study: 29119718

Group type: EXPERIMENTAL
Intervention: Oral prednisolone treatment (15 mg/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 27960026

Group type: EXPERIMENTAL
Intervention: NTVC (Topical vasodilating cream)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 24691252

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (60-70% peak oxygen uptake [VO2peak] for 45 min, 3 days/week)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 34
Study: 22658450

Group type: EXPERIMENTAL
Intervention: Jubilee dressing method
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard adhesive dressing
Number of subjects: 124
Study: 20683462

Group type: EXPERIMENTAL
Intervention: Rice-ORS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glucose-ORS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glucose-ORS plus ARS
Number of subjects: 30
Study: 18338627

Group type: EXPERIMENTAL
Intervention: Oral Chinese materia medica (b. i. d)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Oral carboxymethyl liquor (control)
Number of subjects: 31
Study: 15847251

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg once daily for four weeks, increased to 80 mg if DBP >= 85 mmHg after four or eight weeks.
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Telmisartan treatment
Number of subjects: 82
Study: 12774056

Group type: EXPERIMENTAL
Intervention: Bone marrow donation
Number of subjects: 2

Group type: COMPARATOR
Intervention: Peripheral blood stem cells (PBSCs) donation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: G‐CSF stimulated stem cell donation
Number of subjects: 2
Study: 10420392

Group type: EXPERIMENTAL
Intervention: Microcrystalline chitosan (MCCh; 3 capsules, each 400 mg b.i.d.)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Microcrystalline chitosan (MCCh)
Number of subjects: 51
Study: 8024918

Group type: EXPERIMENTAL
Intervention: Preincisional ilioinguinal and iliohypogastric nerve block and wound infiltration with 0.5% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40
Study: 2702229

Group type: EXPERIMENTAL
Intervention: Metered dose inhaler use
Number of subjects: 238